Enterome vs ReAlta Life Sciences

Enterome vs ReAlta Life Sciences, compared side by side on 14 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Enterome is on 60/100 and ReAlta Life Sciences on 42/100.

Enterome logo
EnteromeClinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.
Try Enterome
ReAlta Life SciencesDeveloping novel therapeutics for inflammatory and hypoxic diseases.
Try ReAlta Life Sciences

Where each one leads

Enterome

  • our overall score: 60/100 against 42/100
  • funding raised: $124M against $55.0M

ReAlta Life Sciences

  • agent readiness: 25/100 against 21/100

At a glance

MeasureEnteromeReAlta Life Sciences
What it isClinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.Developing novel therapeutics for inflammatory and hypoxic diseases.
CategoryBiotechnology, Drug Discovery, Oncology, ImmunotherapyBiotechnology, Pharmaceuticals, Healthcare, Biotech
Sells toBusiness modelB2BB2B
OfferingSoftware | hardware | services | marketplace | platformServices
Founded20122016
HeadquartersParis, FranceNorfolk, USA
StatusActiveActive

Size, funding and growth

MeasureEnteromeReAlta Life Sciences
Employees33Not published
Total funding$124M$55.0M
Latest roundLater Stage VCFunding Round
LinkedIn followers16,846Not published

StartupHub scores

Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.

MeasureEnteromeReAlta Life Sciences
StartupHub scoreOur 0-100 rating60/10042/100
Traction55/10039/100
Team70/100Not published
Search visibility34/10013/100
Quality68/10058/100
Agent readinessHow well an AI agent can read and act on the siteF (21/100)F (25/100)
Domain ratingLink authority, 0-10046/100Not published

Technology

Detected on each public site, so it reflects the marketing stack as well as the product.

MeasureEnteromeReAlta Life Sciences
HostingSelf ManagedNot detected
CMSWordPressNot detected
FrameworksBootstrapNot detected
AnalyticsGoogle Analytics 4, SegmentNot detected

Enterome vs ReAlta Life Sciences: common questions

Which is better, Enterome or ReAlta Life Sciences?

On our 0-100 score Enterome rates higher (60/100 against 42/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 14 data points above: read the rows that match what you are buying for.

How do Enterome and ReAlta Life Sciences compare on the numbers?

Enterome leads on our overall score (60/100 against 42/100), funding raised ($124M against $55.0M). ReAlta Life Sciences leads on agent readiness (25/100 against 21/100).

Read the full Enterome review and pricing or the ReAlta Life Sciences review and pricing. You can also browse other Enterome alternatives we track.